RA

Rosalind Advisors Portfolio holdings

AUM $207M
1-Year Est. Return 62.29%
This Quarter Est. Return
1 Year Est. Return
+62.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
+$1.42M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$13.2M
2
+$7.77M
3
+$5.02M
4
DCTH icon
Delcath Systems
DCTH
+$4M
5
FENC icon
Fennec Pharmaceuticals
FENC
+$2.18M

Top Sells

1
+$8.6M
2
+$5.58M
3
+$4.31M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$3.97M
5
VSTM icon
Verastem
VSTM
+$2.49M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCTH icon
1
Delcath Systems
DCTH
$432M
$33M 15.65%
3,300,389
+400,000
FENC icon
2
Fennec Pharmaceuticals
FENC
$240M
$17M 8.05%
2,045,644
+262,800
CYTK icon
3
Cytokinetics
CYTK
$7.05B
$13.2M 6.27%
+400,000
OCUL icon
4
Ocular Therapeutix
OCUL
$2.59B
$11.3M 5.36%
1,218,700
IDYA icon
5
IDEAYA Biosciences
IDYA
$2.43B
$10.7M 5.09%
511,132
-188,868
XERS icon
6
Xeris Biopharma Holdings
XERS
$1.48B
$10.1M 4.77%
2,155,594
-340,392
VRDN icon
7
Viridian Therapeutics
VRDN
$1.88B
$9.79M 4.64%
700,000
+105,000
VRNA
8
DELISTED
Verona Pharma
VRNA
$9.46M 4.48%
100,000
VSTM icon
9
Verastem
VSTM
$585M
$8.48M 4.02%
2,043,563
-600,954
REPL icon
10
Replimune Group
REPL
$365M
$8.36M 3.96%
900,000
+50,000
MDWD icon
11
MediWound
MDWD
$250M
$7.88M 3.74%
407,061
-99,832
MYO icon
12
Myomo
MYO
$40.8M
$7.77M 3.68%
3,595,788
+892,127
RZLT icon
13
Rezolute
RZLT
$806M
$7.77M 3.68%
+1,741,211
URGN icon
14
UroGen Pharma
URGN
$783M
$7.43M 3.52%
542,366
-407,634
CYBN
15
Cybin
CYBN
$154M
$6.8M 3.23%
810,918
SVRA icon
16
Savara
SVRA
$619M
$6.05M 2.87%
2,654,944
NSPR icon
17
InspireMD
NSPR
$99.3M
$5.2M 2.46%
2,289,099
+14,109
CGON icon
18
CG Oncology
CGON
$3.19B
$5.02M 2.38%
+192,974
PROF
19
Profound Medical
PROF
$167M
$4.08M 1.94%
692,185
PHVS icon
20
Pharvaris
PHVS
$1.41B
$3.94M 1.87%
223,627
PYPD icon
21
PolyPid
PYPD
$53.3M
$3.44M 1.63%
975,462
-42,559
MNMD icon
22
MindMed
MNMD
$906M
$2.73M 1.29%
420,000
KALV icon
23
KalVista Pharmaceuticals
KALV
$558M
$1.78M 0.85%
157,725
-146,139
TRVI icon
24
Trevi Therapeutics
TRVI
$1.29B
$1.64M 0.78%
300,000
-312,901
CMPS
25
Compass Pathways
CMPS
$615M
$1.35M 0.64%
482,651
-340,635
1
2